CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in UNITED STATES : Lifevantage Corp (2019 sales of $225.96 million ), Assertio Holdings Inc ($229.50 million of which 100% was Pharmasuticals), and Vanda Pharmaceuticals Inc. ($227.19 million of which 63% was Hetlioz).

Sales Analysis. Sales increased substantially in 2019: During the year ended December of 2019, sales at Alnylam Pharmaceuticals were $219.75 million. This is an increase of 193.4% versus 2018, when the company's sales were $74.91 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 132.26
(Figures in U.S. Dollars)
1 Week 8.0%   13 Weeks -3.2%  
4 Weeks -12.2%   52 Weeks 52.9%  
 
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 219,750,000
(Year Ending Jan 2020).
Employees: 1,323
  Currency: U.S. Dollars Market Cap: 15,295,472,220
  Fiscal Yr Ends: December Shares Outstanding: 115,647,000
  Share Type: Common Closely Held Shares: 945,972
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.